Rhinology & Endoscopic Skull Base Surgery — Specialty Profile

Exploratory, not prescriptive. This profile blends hard data (pay, match rates, burnout, demographics, each sourced and dated) with generalizations and synthesized opinion about culture and "who fits." It's here to help you get curious and go find out for yourself, not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Last reviewed: 2026-08-04.

Also called: rhinology, sinus surgery, endoscopic sinus and skull base surgery, anterior skull base surgery. A 1-year society-matched fellowship entered after an otolaryngology residency, without ACGME accreditation or a board certificate. Organ systems: the nose and paranasal sinuses, and the anterior skull base directly above them.

Subspecialty fellowship of Otolaryngology — Head & Neck Surgery.

The 30-second version

Rhinology owns the most commonly performed subspecialty operation in otolaryngology and has no board certificate to go with it. Endoscopic sinus surgery is done tens of thousands of times a year in the United States, and the fellowship that trains its experts is not ACGME-accredited, leads to no ABOHNS subcertificate, and belongs to a society that explicitly does not regulate how long it lasts or what it contains. The clinical work has two halves that pull in opposite directions. The sinus half is being reshaped faster than any other part of otolaryngology by biologic drugs, which are now displacing operations that used to be inevitable. The skull base half is expanding, because the endonasal corridor has become the standard approach to the pituitary and much of the anterior skull base, and the rhinologist is the surgeon who builds and closes that corridor while a neurosurgeon works through it. The trade at the center: the highest-volume, most private-practice-compatible subspecialty in otolaryngology, credentialed by reputation rather than by a board.

Quick dashboard (details and sources below)


Training after med school	6 years (5 yr otolaryngology residency + 1 yr rhinology fellowship)
Total from college start	~14 years (4 undergrad + 4 med school + 5 residency + 1 fellowship)
Training chain	Med school (4) → Otolaryngology (5) → 1-yr rhinology fellowship (SF Match, ARS-sponsored) → no subspecialty board
Competitiveness	The residency is the hard door. ~32 fellowship programs, mostly one fellow each ⟳
Typical full-time pay	No benchmark isolates it. Parent otolaryngology runs ~$510,000–$525,000 ⟳
Pay vs. parent (general ENT)	At or above, since the practice is high-volume and private-practice-compatible ⟳
Lifestyle	Clinic-heavy, high-throughput OR, light call, with skull base days as the exception ⟳
Burnout	No subspecialty figure; parent otolaryngology ~43%, toward the less-burned-out end ⟳
% women	No subspecialty figure; parent otolaryngology ~23% practicing, 45.3% of residents (ACGME, AY2024-25) ⟳
DO / IMG accessibility	Poor at the residency door: 6.2% DO and 3.2% IMG of matched otolaryngology positions (NRMP 2026) ⟳

What they actually do

Chronic rhinosinusitis is the population. It affects a large share of adults, it is miserable rather than dangerous, and it fills the clinic. The rhinologist sees the patients whose disease did not respond to primary treatment, whose previous surgery failed, or whose polyps came back.

Endoscopic sinus surgery is the core operation, and the fellowship-trained version of it is the revision and the complex case: scarred anatomy, frontal sinus disease, extensive polyposis, and the sinuses of people who have already been operated on several times.

Biologic therapy has changed this half of the practice faster than anything else in otolaryngology. Monoclonal antibodies for chronic rhinosinusitis with nasal polyps are now a routine alternative to repeat surgery, and the uptake is lopsided: dupilumab accounts for roughly 89.8% of biologic use in this population, with mepolizumab at 5.3% and omalizumab at 4.8%.¹ The effect on surgical patterns is measurable. Among patients starting a biologic, the share who had already undergone more than three sinus operations fell from 28.3% in 2019 and 2020 to 13.0% in 2023, which indicates the drugs are being started far earlier in the disease course.² ⟳

Endoscopic skull base surgery is the growth half. The endonasal route is now the standard approach to pituitary adenoma and is used for meningioma, craniopharyngioma, chordoma, sinonasal malignancy with skull base extension, and cerebrospinal fluid leak repair. These are two-surgeon operations: the rhinologist opens and closes the corridor and manages the reconstruction, and the neurosurgeon addresses the lesion.

Skull base reconstruction is the technical heart of that collaboration. Preventing a postoperative CSF leak, usually with a vascularized nasoseptal flap, is the thing that determines whether a large endonasal resection is safe to attempt at all.

The rest of the practice: orbital decompression for thyroid eye disease, dacryocystorhinostomy for tear duct obstruction, epistaxis including hereditary hemorrhagic telangiectasia, olfactory disorders, septoplasty and turbinate surgery, and inhalant allergy.

Representative work: revision and complex endoscopic sinus surgery · frontal sinus surgery · management of chronic rhinosinusitis with and without nasal polyps · biologic therapy selection and monitoring · endoscopic endonasal pituitary surgery with neurosurgery · endoscopic resection of anterior skull base and sinonasal tumors · nasoseptal flap and skull base reconstruction · CSF leak repair and encephalocele · endoscopic orbital decompression · dacryocystorhinostomy · epistaxis and HHT management · olfactory dysfunction · septoplasty and inferior turbinate reduction.³

A day in the life: clinic is dominated by the endoscope. Nasal endoscopy is performed on nearly every patient, in the room, in minutes, and it is what makes rhinology a highly diagnostic outpatient practice. Operative days are usually high-throughput sinus lists. Skull base days are the exception and run long with a second surgeon present. A growing share of procedures happens in the office rather than the operating room.

On call: light for the parent specialty's standards. Epistaxis is the recurring call problem, and postoperative CSF leak is the one that matters.

The training path & time to completion

Medical school (4 yrs) → otolaryngology residency (5 yrs) → 1-year rhinology and skull base fellowship → no subspecialty board examination exists.⁴⁵

The fellowship is usually one year, with some two-year programs that add a substantial research component.⁴ ⟳
There are roughly 32 rhinology fellowship programs, most taking a single fellow. The count comes from a published survey of program websites, which identified 32 programs and found that 29 of them, 90.6%, had a website at all.⁶ ⟳
It matches through SF Match, in a process sponsored by the American Rhinologic Society.⁴
The sponsoring society does not regulate the training. ARS sponsors and enforces the rules of the match and maintains a program directory, and states that the directory information comes from program directors and may be inconsistent or out of date. It does not set duration or curriculum.⁴ ⟳
No board certificate exists. ABOHNS offers exactly three subspecialty certifications: Complex Pediatric Otolaryngology, Neurotology, and Sleep Medicine. Rhinology is not among them.⁵
Total from the start of college: about 14 years.

What the missing board actually means. A general otolaryngologist can perform endoscopic sinus surgery without a fellowship and does so routinely, so this fellowship confers expertise rather than permission. Its value is real and it is reputational: complex revision referrals, skull base team membership, and academic appointment. Someone weighing this year against going straight into practice should understand they are buying a case log and a network rather than a credential a hospital can verify on a form.

How competitive is it?

The residency is the genuine bottleneck. Otolaryngology fills at 99.8%, and of the 402 positions that filled in 2026, 88.3% went to US MD seniors, 90.5% to US MD seniors and graduates together, 6.2% to DOs and 3.2% to IMGs.⁷ ⟳
The fellowship is small but not scarce, at roughly 32 programs with mostly one position each.⁶ ⟳
There is no board to sit, so there is no certification pass rate, no diplomate count, and no published workforce census. This subspecialty is measurably less measured than its siblings. ⟳
Demand is broad rather than concentrated, because chronic rhinosinusitis is common everywhere, unlike the tertiary-only diseases that anchor neurotology.

The honest read. If you can get into otolaryngology, you can very likely get a rhinology fellowship. The competition inside otolaryngology is for the well-known programs with high skull base volume, since that is where the reputational value concentrates.

Board: none. Primary certification in otolaryngology–head and neck surgery is the only board credential a rhinologist holds.⁵

Compensation — the robust version

No compensation survey isolates rhinology, and unlike neurotology there is not even a board-certified population to count.

The parent anchor. Otolaryngology runs roughly $510,000–$525,000 nationally, with entry around $290,000, senior figures near $595,000, and private-group owner-partners reaching $700,000–$900,000 and above.⁷ ⟳

Why rhinology sits at or above that anchor, structurally. Three features push the same direction. The disease is common, so volume is available in any market. Much of the practice is high-throughput sinus surgery rather than day-long operations. And an increasing share of procedures is performed in the office, where a practice that owns its equipment captures the facility component. Rhinology is one of the few otolaryngology subspecialties fully compatible with private-group practice, which is where the specialty's highest incomes are made.⁷ ⟳

The counterweight, which is new and worth watching. Biologics are displacing repeat sinus surgery, and the shift toward earlier initiation is documented rather than speculative.¹² A practice built on revision polyp surgery faces a smaller future than it did a decade ago. The medical management of these patients is a clinic activity rather than an operative one, and it pays accordingly. Nobody has yet published what this does to rhinology incomes, and anyone entering the field should treat it as the live economic question. ⟳

The academic fork. Skull base practice concentrates at academic centers with neurosurgical partners, and academic otolaryngology pays roughly 7% below non-academic hospital employment.⁷ The rhinologist who wants the pituitary cases usually takes the academic salary to get them. ⟳

Limited-data caveat: everything above the parent anchor is inference from practice structure, not from a survey, and no MGMA, Doximity, or Medscape line isolating rhinology was located. Benchmark against general otolaryngology in the same market and ask specifically about in-office procedure revenue and the balance between sinus and skull base work. ⟳

Lifestyle

Among the better lifestyles in surgery, inheriting the parent field's clinic-and-OR mix with relatively light call.⁷
High-throughput operating. A sinus list is several cases in a day, which is a different rhythm from the rest of skull base surgery.
Clinic is endoscope-driven and efficient, with diagnosis usually made in the room during the visit.
Skull base days are the outlier, long and shared with neurosurgery.
Call is light, with epistaxis as the recurring nuisance.
Geographic flexibility is good, and this is the field's clearest advantage over its ENT siblings. Sinus disease exists in every market, so a rhinologist is not restricted to tertiary centers the way a neurotologist is.
The office is becoming the operating room, which shortens days and shifts the practice further toward outpatient rhythms.

Lifestyle rating: 4/5. Predictable, outpatient-weighted, and light on emergencies, deducted for the long skull base days and the volume expectations that come with a high-throughput practice.

Wellbeing — the part to take seriously

No rhinology-specific burnout figure was located. Inherit parent otolaryngology at roughly 43%, toward the less-burned-out end of surgical fields.⁷ ⟳

The chronic-disease frustration is the field's defining emotional feature. Chronic rhinosinusitis is a quality-of-life disease that recurs. Patients arrive having been miserable for years, surgery helps many of them substantially, and a meaningful fraction relapse and return. Managing expectations about a condition that is controlled rather than cured is most of the clinic conversation.

The skull base half carries the opposite pressure. A CSF leak after a large endonasal resection is a serious complication, and preventing it depends on a reconstruction the rhinologist performs. Documented rhinologic complications after endoscopic pituitary surgery include epistaxis at about 3% and acute rhinosinusitis at 1.2% early, with prolonged crusting at 15.6%, symptomatic synechiae at 11.9%, and septal perforation at 0.6% later.⁸ Most are nuisances, and the leak is not.

The shared-operation dynamic is unusual and suits some people badly. In endonasal skull base surgery the rhinologist opens, reconstructs, and closes, while the neurosurgeon removes the lesion. It is genuine collaboration and it also means not being the surgeon whose name the case is filed under.

The therapeutic shift is a professional identity question as much as an economic one. A surgeon who trained to operate on polyps now spends part of the clinic deciding who should get an injection instead. Most practitioners describe this as good medicine and some describe it as a smaller job.

The absence of a board has a quiet cost. Without a certificate, expertise is demonstrated by where you trained and what you have operated on, which puts more weight on reputation and networks than most subspecialties require.

Who's in the field (demographics)

No rhinology-specific demographic data was located, and the reason is structural: there is no board certificate, so there is no diplomate registry to count. This subspecialty is genuinely less measured than its ENT siblings, both of which have published workforce studies. ⟳

Women: inherit parent otolaryngology at about 23% of practicing physicians and 45.3% of current residents (ACGME, AY2024-25). Men are still the majority of the resident cohort, at 54.5%, but the pipeline runs roughly twice as female as the workforce it will replace, and that will move the subspecialties over the next two decades.⁷ ⟳
DO: 6.2% of matched otolaryngology positions, 25 of 402 (NRMP 2026).⁷ ⟳
IMG: 3.2% of matched otolaryngology positions, 13 of 402 (NRMP 2026).⁷ ⟳
Underrepresented in medicine: no subspecialty figure. The parent field has the lowest URiM matriculant share of any surgical specialty, at roughly 8.5% across 2010–2018.⁷ ⟳
Fellowship programs: roughly 32, mostly one fellow each, so the annual national output is small.⁶ ⟳

Culture, personality & the online stereotypes

Who gravitates here: otolaryngology residents who like endoscopic work and high-volume operating, and those drawn to the skull base without wanting the temporal bone. The field is technically minded, device- and technology-forward, and comfortable with a chronic-disease clinic. It has a strong private-practice presence alongside its academic skull base wing, which makes it culturally broader than most ENT subspecialties. As always, plenty of people in the field do not fit any single mold.

The stereotypes. Community perception rather than fact, each with a kernel and an unfair edge:

"A fellowship for an operation everyone already does." Fair as a challenge, and the answer is revisions, frontal sinus disease, and the skull base, none of which are general-practice work.
"The fellowship with no board." Literally true, and the field's least comfortable fact.
"Dupilumab is coming for your practice." An exaggeration of a real and documented trend.
"You hold the retractor for neurosurgery." Unfair, since the corridor and the reconstruction are the difficult parts of an endonasal case, but it reflects a genuine question about whose operation it is.

What people say online (synthesized and paraphrased, not quotes): across trainee and physician forums, and Headmirror, rhinology reads as the practical fellowship. The dominant recurring theme is that it is the most private-practice-compatible subspecialty in ENT and the one with the most geographic freedom. A second is the absence of a board, discussed as a real weakness for credentialing and as largely irrelevant in practice. A third is biologics, raised increasingly and with genuine uncertainty about what the operative practice looks like in fifteen years. A fourth is skull base access, described as available only at programs with the neurosurgical partnership to support it, which makes fellowship choice unusually consequential. The tone is pragmatic.

Voices from the field. Paraphrased from published sources, with links to the originals:

The American Rhinologic Society states that it sponsors and enforces the rules of the rhinology fellowship match through SF Match, maintains a program directory populated by program directors, and does not regulate the duration or content of individual fellowships.⁴
ABOHNS states that it offers subcertification in exactly three subspecialties, Complex Pediatric Otolaryngology, Neurotology, and Sleep Medicine.⁵
A published evaluation of rhinology fellowship program websites identified 32 unique programs, of which 29, or 90.6%, had a website at all.⁶

Why people choose it / why people leave

Why choose it: the most geographically flexible subspecialty in otolaryngology, because sinus disease is everywhere · genuine private-practice compatibility, which is where ENT's highest incomes are · high-throughput operating rather than day-long cases · the endoscopic skull base, one of the fastest-growing areas in surgery · a one-year fellowship rather than two · an office-based procedural practice with real autonomy · a technology-forward field that changes quickly.

Why leave or avoid it: no board certificate and no formal accreditation of the training · a chronic recurring disease that frustrates patients and surgeons · biologics reshaping the operative half with the economics not yet understood · shared credit on skull base cases · skull base exposure that depends entirely on which fellowship you land · a residency door among the hardest in medicine.

Best fit if: you want endoscopic surgery and high volume · geographic freedom matters to you · private practice appeals · you are comfortable managing a chronic disease medically as well as surgically · you want skull base work without two more years of training.

Not for you if: you need a board certificate to feel credentialed · recurring disease would wear on you · you want to be the primary surgeon on every case you scrub · you want a tertiary-only referral practice.

The FLI angle — Rhinology & skull base surgery for first-gen, low-income & immigrant students

Where it fits FLI realities well:

It is the shortest and most flexible route to a subspecialty practice in otolaryngology. One year rather than two, with a practice viable in any market and compatible with private-group ownership, which is where the parent specialty's real wealth is built.⁷ For someone whose plan depends on earning meaningfully soon after training, this is the friendliest ENT subspecialty on both axes.
Geography is yours. Chronic rhinosinusitis exists everywhere, so staying near family is compatible with this career in a way it is not with neurotology at 1.1 surgeons per million people.
The patients are ordinary people with a miserable common disease, and access to specialist sinus care and to biologics tracks insurance closely. Biologics in particular are expensive and heavily prior-authorized, so who gets one is a question of coverage as much as of disease.

Risks to name honestly:

The barrier is the residency, and it is severe. Otolaryngology matches at 6.2% DO and 3.2% IMG with the lowest URiM matriculant share of any surgical specialty.⁷ The planning horizon for an FLI student starts in the second year of medical school, and the research and away-rotation costs that make it possible are exactly what is hardest to fund. Confront that early.
An unaccredited fellowship with no board rewards networks, and networks are the thing FLI students most often lack. Where you train and who vouches for you carries more weight here than in a subspecialty with a certificate, so mentorship is not optional.
The economics have a live question mark. Biologics are displacing revision surgery, earlier each year.¹² Nobody knows yet what that does to a rhinology income over a thirty-year career. Do not model this field on its last decade.
PSLF fits worse than in most ENT subspecialties, precisely because the attractive option is private practice. If loan forgiveness is central to your plan, the academic skull base route is the one that qualifies, and it pays roughly 7% less.⁷

Bottom line for FLI: the best combination of geographic freedom, training length, and earning potential among otolaryngology's subspecialties, reached through one of the hardest residency doors in medicine. Its two weaknesses are the missing credential, which puts weight on connections, and a therapeutic shift whose effect on the operative practice nobody has measured yet. Get into otolaryngology first; this decision is five years later.

Fun facts

Its signature operation is among the most commonly performed in otolaryngology, and there is no board certificate in it. ABOHNS certifies exactly three subspecialties and rhinology is not one of them.⁵
The society that runs the fellowship match says outright that it does not regulate how long the fellowship lasts or what it teaches.⁴
One drug dominates the field's medical half: dupilumab accounts for roughly 89.8% of biologic use in chronic rhinosinusitis with nasal polyps, against 5.3% for mepolizumab and 4.8% for omalizumab.¹
Patients starting a biologic are reaching it far earlier than they used to. The share who had already had more than three sinus operations fell from 28.3% in 2019 and 2020 to 13.0% in 2023.²
The standard approach to the pituitary gland now runs through the nostril, and the otolaryngologist builds the corridor the neurosurgeon works through.
A survey of the field's fellowship programs found that 3 of 32 did not have a website at all.⁶

Sources

Biologic utilization. "Real-World Outcomes Following Biologic Initiation in US Patients With Chronic Rhinosinusitis With Nasal Polyps," Annals of Allergy, Asthma & Immunology — dupilumab was the most frequently received biologic at 89.8% of patients receiving one, compared with mepolizumab at 5.3% and omalizumab at 4.8%; 7.1% of patients without prior nasal polyp surgery underwent at least one such surgery during 24 months of follow-up after biologic initiation. https://www.annallergy.org/article/S1081-1206(24)00598-2/fulltext (accessed 2026). ⟳ ↩ ↩² ↩³ ↩⁴
Shift toward earlier biologic initiation. "Evolving trends in dupilumab use for chronic rhinosinusitis with nasal polyps (CRSwNP): a 4-year cohort analysis," Scientific Reports, 2025 — the proportion of patients with more than three prior sinus surgeries at the time of biologic initiation declined from 28.3% in 2019/20 to 13.0% in 2023, indicating earlier initiation over time. https://www.nature.com/articles/s41598-025-17787-4?error=cookies_not_supported&code=aa405486-65d6-47d5-a97d-ab5b8b2a6e78 ⟳ ↩ ↩² ↩³ ↩⁴
Clinical scope. Composite of published US rhinology and skull base fellowship curricula, which consistently cover revision and complex endoscopic sinus surgery, frontal sinus surgery, chronic rhinosinusitis with and without polyps, endoscopic endonasal pituitary and anterior skull base surgery with neurosurgery, nasoseptal flap reconstruction, CSF leak repair, endoscopic orbital decompression, dacryocystorhinostomy, epistaxis and HHT, and olfactory disorders. Vanderbilt University Medical Center (https://www.vumc.org/ent/rhinology-and-skull-base-surgery-fellowship), University of Pennsylvania (https://oto.med.upenn.edu/fellowship-programs/rhinology-and-skull-base-surgery/), Mayo Clinic (https://college.mayo.edu/academics/residencies-and-fellowships/rhinology-and-skull-base-surgery-fellowship-minnesota/application-process/), and Duke (https://headnecksurgery.duke.edu/education-and-training/fellowship-programs/rhinology-and-endoscopic-skull-base-surgery-fellowship/how-apply), accessed 2026. ↩
Fellowship structure and match. American Rhinologic Society rhinology fellowship program listing — fellowships are typically one year, with some two-year programs adding a research component; the match is coordinated through the SF Match Program; ARS sponsors and enforces the rules of the fellowship match and maintains a directory whose information is supplied by program directors and may be inconsistent, inaccurate, or outdated; ARS does not regulate the duration or content of individual fellowships. https://www.american-rhinologic.org/rhinology_fellowship (accessed 2026). ⟳ ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶
Board structure. American Board of Otolaryngology – Head and Neck Surgery — ABOHNS currently offers subcertification for exactly three subspecialties: Complex Pediatric Otolaryngology, Neurotology, and Sleep Medicine. Rhinology is not among them, so no subspecialty board examination in rhinology exists. https://www.abohns.org/about-our-certifications/our-assessment-programs (accessed 2026). ↩ ↩² ↩³ ↩⁴ ↩⁵
Program count. "Evaluation of Rhinology Fellowship Program Websites," PMID 38883451 — 32 unique rhinology fellowship programs were identified, of which 29, or 90.6%, had websites. https://pubmed.ncbi.nlm.nih.gov/38883451/ ⟳ ↩ ↩² ↩³ ↩⁴ ↩⁵
Parent-field figures: otolaryngology typical comp ~$510k–$525k with entry ~$290k, senior ~$595k, and owner-partners $700k–$900k+; non-academic hospital employment averages ~7% above academic; burnout ~43%, toward the less-burned-out end; ~23% women practicing and 45.3% of current residents; 6.2% DO and 3.2% IMG of matched positions, 99.8% fill, 88.3% US MD seniors; lowest URiM matriculant share of any surgical specialty (~8.5%, 2010–2018); "surgery with a lifestyle" clinic/OR mix with relatively light call. See the otolaryngology profile on this site for the full version. Sources for the non-pay figures above. Match figures, NRMP, Results and Data: 2026 Main Residency Match, May 2026, Table 2, https://www.nrmp.org/wp-content/uploads/2026/05/Main_Match_Results_and_Data-2026.pdf : of 403 otolaryngology positions offered, 402 filled (99.8%), taken by 355 U.S. MD seniors (88.3%) and 9 U.S. MD graduates, 23 DO seniors and 2 DO graduates (6.2% together), 5 U.S. IMGs and 8 non-U.S. IMGs (3.2% together). Every share here is of the positions that filled. Women in training, ACGME, Data Resource Book, Academic Year 2024-2025, Table C.21, https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf : 1,883 otolaryngology residents, 853 of them women (45.3%) against 1,027 men (54.5%). Corrected 2026-08-17: this footnote had recorded three disagreements with the body and the body had kept the older figures anyway, in the dashboard, the competitiveness section, the demographics section and the FLI section. The reader-facing text now carries 45.3% women, 3.2% IMG, 6.2% DO and 88.3% U.S. MD seniors. The women figure changed a claim rather than a number: the page had said roughly 51% of residents and built a "majority-women pipeline" reading on it, and 45.3% is not a majority, so the sentence was rewritten rather than renumbered. The ~92% U.S. MD in the old text was closest to MD seniors plus graduates, 90.5%, which is a denominator choice; both are now given with the denominator named. Burnout, Medscape Physician Burnout & Depression Report 2024 (n=9,226, fielded July–October 2023), which is paywalled and is relayed here through Healthgrades Pro (https://resources.healthgrades.com/pro/the-most-and-least-burned-out-physicians-by-specialty) and Advisory Board (https://www.advisory.com/daily-briefing/2024/01/31/physician-burnout), both of which put otolaryngology at 43%, sixth-lowest of the specialties ranked. AAMC's published tables carry no otolaryngology row, so the ~23% women in practice has no primary source behind it here and should be treated as unverified. ⟳ ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹ ↩¹² ↩¹³
Rhinologic complications of endoscopic pituitary surgery. "Rhinologic outcome of endoscopic transnasal-transsphenoidal pituitary surgery: an institutional series, systematic review, and meta-analysis" — early postoperative rhinologic complications included epistaxis 3% and acute rhinosinusitis 1.2%; late complications included prolonged crusting 15.6%, symptomatic synechiae 11.9%, and septal perforation 0.6%. https://pmc.ncbi.nlm.nih.gov/articles/PMC10382340/ (accessed 2026). ⟳ ↩

Researched with AI assistance and reviewed by hand. How this site is made